13 results on '"Husain SA"'
Search Results
2. Perspectives on COVID-19 vaccination among kidney and pancreas transplant recipients living in New York City.
- Author
-
Tsapepas D, Husain SA, King KL, Burgos Y, Cohen DJ, and Mohan S
- Subjects
- Humans, Kidney, Middle Aged, New York City, Pancreas, Retrospective Studies, SARS-CoV-2, Transplant Recipients, Vaccination, COVID-19, COVID-19 Vaccines
- Abstract
Purpose: Solid organ transplant recipients are at increased risk of morbidity and mortality from coronavirus disease 2019 (COVID-19), but limited vaccine access and vaccine hesitancy can complicate efforts for expanded vaccination. We report patient perspectives and outcomes from a vaccine outreach initiative for a vulnerable population of transplant recipients living in New York City., Methods: This was a retrospective review of qualitative perspectives from a COVID-19 vaccine outreach initiative. In the outreach effort, kidney and pancreas transplant recipients under care at the transplant center at NewYork-Presbyterian Hospital were initially contacted electronically with educational material about vaccination followed by telephone outreach to eligible unvaccinated patients. Calls were used to schedule vaccine appointments for patients who agreed, answer questions, and assess attitudes and concerns for patients not yet ready to be vaccinated, with conversational themes recorded., Results: Of the 1,078 patients living in the 5 New York City boroughs who had not reported receiving COVID-19 vaccination, 320 eligible patients were contacted by telephone. Of these, 210 patients were scheduled for vaccination at our vaccine site (including 13 who agreed to vaccination after initially declining), while 110 patients were either not ready or not interested in being vaccinated. The total number of patients willing to be vaccinated was 554 when also including those already vaccinated. Unwillingness to be vaccinated was associated with younger age (median age of 47 vs 60 years, P < 0.001), Black race (P = 0.004), and residence in Bronx or Brooklyn counties (P = 0.018) or a zip code with a medium level of poverty (P = 0.044). The most common issues raised by patients who were ambivalent or not interested in vaccination were regarding unknown safety of the vaccines in general, a belief that there was a lack of data about the vaccines in transplant recipients, and a lack of trust in the scientific process underlying vaccine development, with 34% of the patients contacted expressing vaccine hesitancy overall., Conclusion: Our qualitative summary identifies determinants of COVID-19 vaccine hesitancy in a diverse transplant patient population, supporting the need for transplant centers to implement tailored interventions to increase vaccine acceptance in this vulnerable population., (© American Society of Health-System Pharmacists 2021. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2021
- Full Text
- View/download PDF
3. COVID-19-Associated Mortality among Kidney Transplant Recipients and Candidates in the United States.
- Author
-
Mohan S, King KL, Husain SA, and Schold JD
- Subjects
- Aged, COVID-19 diagnosis, Cause of Death, Female, Humans, Kidney Transplantation adverse effects, Male, Middle Aged, Registries, Risk Assessment, Risk Factors, Time Factors, Treatment Outcome, United States epidemiology, COVID-19 mortality, Kidney Transplantation mortality, Transplant Recipients, Waiting Lists mortality
- Abstract
Background and Objectives: The coronavirus disease 2019 (COVID-19) pandemic has had a profound effect on transplantation activity in the United States and globally. Several single-center reports suggest higher morbidity and mortality among candidates waitlisted for a kidney transplant and recipients of a kidney transplant. We aim to describe 2020 mortality patterns during the COVID-19 pandemic in the United States among kidney transplant candidates and recipients., Design, Setting, Participants, & Measurements: Using national registry data for waitlisted candidates and kidney transplant recipients collected through April 23, 2021, we report demographic and clinical factors associated with COVID-19-related mortality in 2020, other deaths in 2020, and deaths in 2019 among waitlisted candidates and transplant recipients. We quantify excess all-cause deaths among candidate and recipient populations in 2020 and deaths directly attributed to COVID-19 in relation to prepandemic mortality patterns in 2019 and 2018., Results: Among deaths of patients who were waitlisted in 2020, 11% were attributed to COVID-19, and these candidates were more likely to be male, obese, and belong to a racial/ethnic minority group. Nearly one in six deaths (16%) among active transplant recipients in the United States in 2020 was attributed to COVID-19. Recipients who died of COVID-19 were younger, more likely to be obese, had lower educational attainment, and were more likely to belong to racial/ethnic minority groups than those who died of other causes in 2020 or 2019. We found higher overall mortality in 2020 among waitlisted candidates (24%) than among kidney transplant recipients (20%) compared with 2019., Conclusions: Our analysis demonstrates higher rates of mortality associated with COVID-19 among waitlisted candidates and kidney transplant recipients in the United States in 2020., (Copyright © 2021 by the American Society of Nephrology.)
- Published
- 2021
- Full Text
- View/download PDF
4. Clinically Significant COVID-19 Following SARS-CoV-2 Vaccination in Kidney Transplant Recipients.
- Author
-
Tsapepas D, Paget K, Mohan S, Cohen DJ, and Husain SA
- Subjects
- COVID-19 Serological Testing methods, Female, Humans, Male, Middle Aged, New York epidemiology, Outcome and Process Assessment, Health Care, Patient Care methods, SARS-CoV-2 isolation & purification, Severity of Illness Index, COVID-19 diagnosis, COVID-19 epidemiology, COVID-19 immunology, COVID-19 prevention & control, COVID-19 Vaccines administration & dosage, COVID-19 Vaccines immunology, Immunogenicity, Vaccine immunology, Kidney Transplantation adverse effects, Kidney Transplantation methods, Transplant Recipients statistics & numerical data
- Published
- 2021
- Full Text
- View/download PDF
5. Disparity between levels of anti-RBD IgG and anti-nucleocapsid protein IgG antibodies in COVID-19-recovered patients who received a kidney transplant.
- Author
-
Chang CC, Vlad G, Vasilescu ER, Husain SA, Liu YN, Sun WZ, Chang MF, Suciu-Foca N, and Mohan S
- Subjects
- Antibodies, Viral, Humans, Immunoglobulin G, Nucleocapsid Proteins, SARS-CoV-2, COVID-19, Kidney Transplantation adverse effects
- Published
- 2021
- Full Text
- View/download PDF
6. COVID-19 mortality among kidney transplant candidates is strongly associated with social determinants of health.
- Author
-
Schold JD, King KL, Husain SA, Poggio ED, Buccini LD, and Mohan S
- Subjects
- Humans, Male, Pandemics, SARS-CoV-2, Social Determinants of Health, United States epidemiology, COVID-19, Kidney Transplantation adverse effects
- Abstract
The COVID-19 pandemic has affected all portions of the global population. However, many factors have been shown to be particularly associated with COVID-19 mortality including demographic characteristics, behavior, comorbidities, and social conditions. Kidney transplant candidates may be particularly vulnerable to COVID-19 as many are dialysis-dependent and have comorbid conditions. We examined factors associated with COVID-19 mortality among kidney transplant candidates from the National Scientific Registry of Transplant Recipients from March 1 to December 1, 2020. We evaluated crude rates and multivariable incident rate ratios (IRR) of COVID-19 mortality. There were 131 659 candidates during the study period with 3534 all-cause deaths and 384 denoted a COVID-19 cause (5.00/1000 person years). Factors associated with increased COVID-19 mortality included increased age, males, higher body mass index, and diabetes. In addition, Blacks (IRR = 1.96, 95% C.I.: 1.43-2.69) and Hispanics (IRR = 3.38, 95% C.I.: 2.46-4.66) had higher COVID-19 mortality relative to Whites. Patients with lower educational attainment, high school or less (IRR = 1.93, 95% C.I.: 1.19-3.12, relative to post-graduate), Medicaid insurance (IRR = 1.73, 95% C.I.: 1.26-2.39, relative to private), residence in most distressed neighborhoods (fifth quintile IRR = 1.93, 95% C.I.: 1.28-2.90, relative to first quintile), and most urban and most rural had higher adjusted rates of COVID-19 mortality. Among kidney transplant candidates in the United States, social determinants of health in addition to demographic and clinical factors are significantly associated with COVID-19 mortality., (© 2021 The American Society of Transplantation and the American Society of Transplant Surgeons.)
- Published
- 2021
- Full Text
- View/download PDF
7. Increased Mortality Associated with Hypermagnesemia in Severe COVID-19 Illness.
- Author
-
Stevens JS, Moses AA, Nickolas TL, Husain SA, and Mohan S
- Subjects
- Humans, Magnesium, Male, Retrospective Studies, SARS-CoV-2, Acute Kidney Injury epidemiology, COVID-19 epidemiology
- Abstract
Background: Although electrolyte abnormalities are common among patients with COVID-19, very little has been reported on magnesium homeostasis in these patients. Here we report the incidence of hypermagnesemia, and its association with outcomes among patients admitted with COVID-19., Methods: We retrospectively identified all patients with a positive test result for SARS-CoV-2 who were admitted to a large quaternary care center in New York City in spring 2020. Details of the patients' demographics and hospital course were obtained retrospectively from medical records. Patients were defined as having hypermagnesemia if their median magnesium over the course of their hospitalization was >2.4 mg/dl., Results: A total of 1685 patients hospitalized with COVID-19 had their magnesium levels checked during their hospitalization, and were included in the final study cohort, among whom 355 (21%) had hypermagnesemia. Patients who were hypermagnesemic had a higher incidence of shock requiring pressors (35% vs 27%, P <0.01), respiratory failure requiring mechanical ventilation (28% vs 21%, P =0.01), AKI (65% vs 50%, P <0.001), and AKI severe enough to require renal replacement therapy (18% vs 5%, P <0.001). In an adjusted multivariable model, hypermagnesemia was observed more commonly with increasing age, male sex, AKI requiring RRT, hyperkalemia, and higher CPK. Survival probability at 30 days was 34% for the patients with hypermagnesemia, compared with 65% for patients without hypermagnesemia. An adjusted multivariable time to event analysis identified an increased risk of mortality with older age, need for vasopressors, higher C-reactive protein levels, and hypermagnesemia (HR, 2.03; 95% CI, 1.63 to 2.54, P <0.001)., Conclusions: In conclusion, we identified an association between hypermagnesemia among patients hospitalized with COVID-19 and increased mortality. Although the exact mechanism of this relationship remains unclear, hypermagnesemia potentially represents increased cell turnover and higher severity of illness, which is frequently associated with more severe forms of AKI., Competing Interests: S. Mohan reports having consultancy agreements with Angion Biomedica; reports receiving research funding from Angion Biomedica; reports being a scientific advisor or having membership as Deputy Editor, Kidney International Reports (International Society of Nephrology); Vice Chair, United Network for Organ Sharing, Data Advisory committee; member of the Scientific Registry of Transplant Recipients Visiting Committee, ASN Quality committee, and the Angion Pharma scientific advisory board. T. L. Nickolas reports having consultancy agreements with Pharmacosmos; reports receiving research funding from Amgen; reports having patents and inventions from Columbia University, which has licensed patents on neutrophil gelatinase-associated lipocalin to Abbott Diagnostics and Alere; reports being a scientific advisor or member of Amgen, and Pharmacosmos. All remaining authors have nothing to disclose., (Copyright © 2021 by the American Society of Nephrology.)
- Published
- 2021
- Full Text
- View/download PDF
8. SARS-CoV-2 infection increases tacrolimus concentrations in solid-organ transplant recipients.
- Author
-
Salerno DM, Kovac D, Corbo H, Jennings DL, Lee J, Choe J, Scheffert J, Hedvat J, Chen J, Tsapepas D, Rosenblatt R, Samstein B, Halazun K, Verna E, Pereira M, Brennan C, Husain SA, Mohan S, and Brown RS Jr
- Subjects
- Adult, Comorbidity, Female, Graft Rejection epidemiology, Graft Rejection metabolism, Humans, Immunosuppressive Agents pharmacokinetics, Male, Middle Aged, Pandemics, COVID-19 epidemiology, Graft Rejection drug therapy, Organ Transplantation, SARS-CoV-2, Tacrolimus pharmacokinetics, Transplant Recipients
- Published
- 2021
- Full Text
- View/download PDF
9. Review of hygiene adaptations among UK doctors in controlling the spread of SARS-CoV-2 infection.
- Author
-
Husain SA, Husain SA, Khan OU, D'Cruz L, and Allgar V
- Subjects
- COVID-19 transmission, Female, Humans, Male, Retrospective Studies, SARS-CoV-2, United Kingdom epidemiology, COVID-19 epidemiology, Disease Transmission, Infectious prevention & control, Hygiene, Pandemics, Physicians, Workplace standards
- Abstract
Background: A significant number of healthcare workers around the world have contracted COVID-19 from their workplace, thus there is a need to investigate common hygiene practices., Aim: We aimed to describe the common hygiene adaptations of doctors in the hospital and at home., Methods: A survey of 110 doctors in UK was carried out to determine their hygiene adaptations and practices. Data were collected on demographics and personal protective equipment compliance., Results: The key findings were frequent hand washing (51%), change of clothing entering and leaving hospital (88% and 92%, respectively), taking a shower upon returning home (85%) and washing work attire at temperatures of 60-80°C (50%). A higher proportion of junior doctors washed their scrubs (p=0.004) and stethoscopes (p=0.014) compared with consultants and seniors. Female doctors cleaned their mobile phones (p=0.022) and work belongings (p=0.01) more frequently., Conclusion: This study signified that junior doctors were more meticulous in hygiene adaptations and female doctors were more fastidious in personal hygiene. The observations of this study may be beneficial in preventing transmission of infection to families of healthcare professionals and are important to implement in the case of a second wave of COVID-19., (© Royal College of Physicians 2021. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
10. High rate of renal recovery in survivors of COVID-19 associated acute renal failure requiring renal replacement therapy.
- Author
-
Stevens JS, King KL, Robbins-Juarez SY, Khairallah P, Toma K, Alvarado Verduzco H, Daniel E, Douglas D, Moses AA, Peleg Y, Starakiewicz P, Li MT, Kim DW, Yu K, Qian L, Shah VH, O'Donnell MR, Cummings MJ, Zucker J, Natarajan K, Perotte A, Tsapepas D, Krzysztof K, Dube G, Siddall E, Shirazian S, Nickolas TL, Rao MK, Barasch JM, Valeri AM, Radhakrishnan J, Gharavi AG, Husain SA, and Mohan S
- Subjects
- Acute Kidney Injury virology, Aged, Critical Illness mortality, Female, Humans, Intensive Care Units, Kidney virology, Male, Middle Aged, New York City, Proportional Hazards Models, Renal Replacement Therapy methods, Retrospective Studies, SARS-CoV-2 pathogenicity, Survivors, Acute Kidney Injury etiology, Acute Kidney Injury pathology, COVID-19 complications, Kidney pathology
- Abstract
Introduction: A large proportion of patients with COVID-19 develop acute kidney injury (AKI). While the most severe of these cases require renal replacement therapy (RRT), little is known about their clinical course., Methods: We describe the clinical characteristics of COVID-19 patients in the ICU with AKI requiring RRT at an academic medical center in New York City and followed patients for outcomes of death and renal recovery using time-to-event analyses., Results: Our cohort of 115 patients represented 23% of all ICU admissions at our center, with a peak prevalence of 29%. Patients were followed for a median of 29 days (2542 total patient-RRT-days; median 54 days for survivors). Mechanical ventilation and vasopressor use were common (99% and 84%, respectively), and the median Sequential Organ Function Assessment (SOFA) score was 14. By the end of follow-up 51% died, 41% recovered kidney function (84% of survivors), and 8% still needed RRT (survival probability at 60 days: 0.46 [95% CI: 0.36-0.56])). In an adjusted Cox model, coronary artery disease and chronic obstructive pulmonary disease were associated with increased mortality (HRs: 3.99 [95% CI 1.46-10.90] and 3.10 [95% CI 1.25-7.66]) as were angiotensin-converting-enzyme inhibitors (HR 2.33 [95% CI 1.21-4.47]) and a SOFA score >15 (HR 3.46 [95% CI 1.65-7.25)., Conclusions and Relevance: Our analysis demonstrates the high prevalence of AKI requiring RRT among critically ill patients with COVID-19 and is associated with a high mortality, however, the rate of renal recovery is high among survivors and should inform shared-decision making., Competing Interests: The authors declare that they have no financial conflicts of interest to disclose. MRO and MJC are both investigators for Remdesivir (sponsored by Gilead) and convalescent plasma (sponsored by Amazon). This does not alter our adherence to PLOS ONE policies on sharing data and materials.
- Published
- 2020
- Full Text
- View/download PDF
11. Telehealth in outpatient management of kidney transplant recipients during COVID-19 pandemic in New York.
- Author
-
Chang JH, Diop M, Burgos YL, Blackstock DM, Fernandez HE, Morris HK, Dube GK, Crew RJ, Mohan S, Husain SA, Cohen DJ, and Tsapepas DS
- Subjects
- Adult, Aged, Aged, 80 and over, COVID-19 epidemiology, Female, Humans, Male, Middle Aged, New York City epidemiology, Outcome and Process Assessment, Health Care, Pandemics, Ambulatory Care methods, COVID-19 prevention & control, Kidney Transplantation, Physical Distancing, Postoperative Care methods, Telemedicine methods
- Published
- 2020
- Full Text
- View/download PDF
12. COVID-19 in pancreas transplant recipients.
- Author
-
Dube GK, Husain SA, McCune KR, Sandoval PR, Ratner LE, and Cohen DJ
- Subjects
- Adult, Ambulatory Care, COVID-19 immunology, COVID-19 physiopathology, Deprescriptions, Diabetes Mellitus, Type 1 surgery, Diabetic Nephropathies surgery, Female, Graft Rejection prevention & control, Hospitalization, Humans, Immunosuppressive Agents therapeutic use, Kidney Failure, Chronic surgery, Male, Middle Aged, Respiratory Insufficiency physiopathology, SARS-CoV-2, COVID-19 therapy, Kidney Transplantation, Pancreas Transplantation, Telemedicine
- Abstract
Coronavirus disease 2019 (COVID-19) has become a pandemic since first being described in January 2020. Clinical manifestations in non-transplant patients range from asymptomatic infection to severe pneumonia with acute respiratory distress syndrome, multiorgan system failure, and death. Limited reports in kidney transplant recipients suggest similar characteristics in that population. We report here the first case series of COVID-19 infection occurring in pancreas transplant recipients., (© 2020 Wiley Periodicals LLC.)
- Published
- 2020
- Full Text
- View/download PDF
13. Tocilizumab for severe COVID-19 in solid organ transplant recipients: a matched cohort study.
- Author
-
Pereira MR, Aversa MM, Farr MA, Miko BA, Aaron JG, Mohan S, Cohen DJ, Husain SA, Ratner LE, Arcasoy S, Uriel N, Zheng EX, Fox AN, Tsapepas DS, Emond JC, and Verna EC
- Subjects
- Aged, Comorbidity, Female, Graft Rejection epidemiology, Humans, Male, Middle Aged, Pandemics, Antibodies, Monoclonal, Humanized therapeutic use, COVID-19 epidemiology, Graft Rejection prevention & control, Organ Transplantation, SARS-CoV-2, Transplant Recipients
- Abstract
The safety and efficacy of tocilizumab for the treatment of severe respiratory symptoms due to COVID-19 remain uncertain, in particular among solid organ transplant (SOT) recipients. Thus, we evaluated the clinical characteristics and outcomes of 29 hospitalized SOT recipients who received tocilizumab for severe COVID-19, compared to a matched control group who did not. Among a total of 117 total SOT recipients hospitalized with COVID-19, 29 (24.8%) received tocilizumab. The 90-day mortality was significantly higher among patients who received tocilizumab (41%) compared to those who did not (20%, P = .03). When compared to control patients matched by age, hypertension, chronic kidney disease, and administration of high dose corticosteroids, there was no significant difference in mortality (41% vs 28%, P = .27), hospital discharge (52% vs 72%, P = .26), or secondary infections (34% vs 24%, P = .55). Among patients who received tocilizumab, there was also no difference in mortality based on the level of oxygen support (intubated vs not intubated) at the time of tocilizumab initiation. In this matched cohort study, tocilizumab appeared to be safe but was not associated with decreased 90-day mortality. Larger randomized studies are needed to identify whether there are subsets of SOT recipients who may benefit from tocilizumab for treatment of COVID-19., (© 2020 The American Society of Transplantation and the American Society of Transplant Surgeons.)
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.